Voglimik 0.2mg Tablet DT
Marketer
Mikayla Life Sciences Pvt. Ltd.
Salt Composition
Voglibose (0.2mg)
Overview Voglimik 0.2mg Tablet DT
Diabetol 0.2mg Tablet DT is a medication for managing type 2 diabetes. It regulates postprandial hyperglycemia, employed when dietary modifications and other similar treatments prove insufficient. Diabetol 0.2mg Tablet DT should be administered immediately before meals; dosage frequency is determined by your physician to optimize blood glucose control. Abrupt cessation is strongly discouraged; consult your doctor first, as this may cause dangerously elevated blood sugar, potentially leading to complications such as renal impairment and visual disturbances. This medication forms part of a comprehensive treatment plan including diet, exercise, and weight management, as directed by your healthcare provider. Regular blood glucose monitoring is essential. Common adverse effects include gas, abdominal discomfort, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Diabetol 0.2mg Tablet DT itself does not induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) increases this risk. Hypoglycemic episodes necessitate treatment with plain glucose; ordinary table sugar is ineffective in such instances. Inform your doctor of any kidney or liver conditions prior to commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating individuals require medical consultation before use. Disclose all medications you are currently taking to ensure safety and efficacy. Limit alcohol consumption as it may heighten the risk of hypoglycemia.
Uses of Voglimik 0.2mg Tablet DT
Managing Type 2 Diabetes
Major Benefits of Voglimik 0.2mg Tablet DT:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Voglimik 0.2mg Tablet DT in water before consumption. Administer on an empty stomach.
Common Side effects of Voglimik 0.2mg Tablet DT:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglimik 0.2mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Voglimik 0.2mg Tablet DT in water before consumption. Administer on an empty stomach.
How Voglimik 0.2mg Tablet DT works:
Voglimik 0.2mg Delayed-Release Tablets are used to manage diabetes. Their mechanism involves blocking intestinal enzymes that digest complex carbohydrates, thus moderating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglimik 0.2mg Tablet DT and alcohol is strongly discouraged due to safety concerns.
PregnancySAFE IF PRESCRIBED
The use of Voglimik 0.2mg Tablet DT during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglimik 0.2mg Tablet DT safely. Available human data indicates minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by Voglimik 0.2mg Tablet DT.
KidneyCAUTION
Use Voglimik 0.2mg Tablet DT cautiously in patients exhibiting severe renal impairment. Dosage modification of Voglimik 0.2mg Tablet DT might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglimik 0.2mg Tablet DT cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Voglimik 0.2mg Tablet DT :
Omit any missed Voglimik 0.2mg Tablet DT dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglimik 0.2mg Tablet DT
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
3,018 People bought this recently